MedPath

Laparoscopic Supracervical Hysterectomy and Sacropexy Versus Hysteropexy Study

Not Applicable
Conditions
Uterus Prolapse
Interventions
Procedure: Laparoscopic Supracervical Hysterectomy and Sacropexy
Procedure: Laparoscopic Hysteropexy
Registration Number
NCT02345954
Lead Sponsor
Kantonsspital Aarau
Brief Summary

The purpose of this study is to compare the operative, anatomic functional outcome as well as the subjective outcome of laparoscopic supracervical hysterectomy and sacropexy compared to laparoscopic hysteropexy (conserving the uterus).

The investigators expect that both laparoscopic procedures are equal in regards to operation time, complication rate, anatomic and functional outcome as well as subjective outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Patients older than 18 years
  • Symptomatic uterus prolapse (uterus < 300g)
  • Patient able to sign the informed consent and to fulfil the follow up visits
Exclusion Criteria
  • Indication: Pathologies of the uterus (postmen. bleeding, high endometrium at ultrasound (>5 mm), abnormal PAP smear in the last 5 years, bleeding anomalies in premenopausal patients

  • General medical contraindications to a surgical operation

    • tumor/ malignant disease
    • bacterial infection at time of surgery
    • drug or medication abuse at time or just before surfer
  • Disease which would make a correct assessment of the patient impossible (e.g. psychiatric condition)

  • Known hypersensitivity to the implanted materials

  • Immaturity, inability to answer/understand questions

  • Planned pregnancy

  • Participation to other studies (drugs or medical techniques) which could influence the results of this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Supracervical Hysterectomy and SacropexyLaparoscopic Supracervical Hysterectomy and SacropexyLaparoscopic Supracervical Hysterectomy and Sacropexy
HysteropexyLaparoscopic HysteropexyLaparoscopic Hysteropexy
Primary Outcome Measures
NameTimeMethod
Operation timeexpected average of 150 minutes

Comparison of operation time in the 2 arms of the study

Secondary Outcome Measures
NameTimeMethod
Intra- and postoperative complication rate1 year
Duration of anaesthesiaexpected average of 200 minutes
IUGA Pelvic Organ Prolapse Quantification (POP-Q)8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention
Quality of Life8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention

EQ-5D-5L questionnaire

Patient satisfaction after surgeryAt follow up 6 weeks, 6 months and 12 months after intervention
Bladder and bowel function, Prolapse symptoms, Sexuality8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention

Assessed via Pelvic Function Questionnaire

Trial Locations

Locations (1)

Kantonsspital Aarau

🇨🇭

Aarau, Aargau (AG), Switzerland

© Copyright 2025. All Rights Reserved by MedPath